z-logo
open-access-imgOpen Access
Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic
Author(s) -
M Dunn,
Fernanda C. Lessa,
Jacqueline Sánchez,
Ramona Cordero,
Jesús Feris-Iglesias,
Doraliza Cedano,
Maria da Glória Carvalho,
Josefina Fernández,
Kristen A. Feemster
Publication year - 2021
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiab172
Subject(s) - pneumococcal conjugate vaccine , medicine , streptococcus pneumoniae , vaccination , carriage , pneumococcal infections , pediatrics , confidence interval , cohort , odds ratio , immunology , antibiotics , biology , pathology , microbiology and biotechnology
Invasive pneumococcal disease (IPD) leads to thousands of pediatric deaths annually. Pneumococcal colonization precedes IPD. In 2013, the Dominican Republic introduced the 13-valent pneumococcal conjugate vaccine (PCV13) into its routine infant immunization program, with doses at ages 2, 4, and 12 months. Prevalence of pneumococcal nasopharyngeal colonization was evaluated post-PCV13 introduction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom